We serve patients from Scottsdale AZ, Tempe AZ, Mesa AZ, Paradise Valley AZ, Chandler AZ, Phoenix AZ, and surrounding areas
Studies of tirzepatide (the active ingredient in Zepbound and Mounjaro) have found a similar pattern
It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
Study and results: The SELECT trial was a multicenter, double-blind, randomized, placebo-controlled, event-driven superiority trial, conducted at 804 clinical sites in 41 countries
The Phase 2 data proves it: fast escalation to 8 mg doubled GI adverse event rates compared to gradual titration
Injections, drops, or lozenges